Company / Interest Expense
LEXICON PHARMACEUTICALS, INC. Interest Expense History
FY2013-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$14.5M
FY2019
5-year range
$6.6M / $14.5M
FY2015-FY2019
Trend
+121.5%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense has fluctuated over the past 7 years, ranging from $2M in FY2015 to $15M in FY2019.
Based on SEC 10-K filings.
$15M in FY2019 with a 5-year CAGR of +47.1%.
Increased from $7M to $15M over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +86.2%
- 5-Year CAGR
- +47.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +47.1%, indicating consistent growth.
- In FY2019, interest expense increased 121.5% year-over-year.
- Lowest interest expense in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2019 | $14.5M | +121.5% |
| FY2018 | $6.6M | -2.3% |
| FY2017 | $6.7M | +198.4% |
| FY2016 | $2.3M | +14.3% |
| FY2015 | $2.0M | -6.8% |
| FY2014 | $2.1M | -16.4% |
| FY2013 | $2.5M | -7.0% |
As of FY2019 · SEC 10-K Annual Filings · Updated Jun 24, 2026